First Horizon Advisors, Inc. Novartis Ag Transaction History

First Horizon Advisors, Inc.

  • $3.58 Billion
  • Q3 2024

A detailed history of First Horizon Advisors, Inc. transactions in Novartis Ag stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 14,389 shares of NVS stock, worth $1.42 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
14,389
Previous 14,066 2.3%
Holding current value
$1.42 Million
Previous $1.5 Million 10.55%
% of portfolio
0.05%
Previous 0.05%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
BUY
$106.13 - $120.89 $34,279 - $39,047
323 Added 2.3%
14,389 $1.66 Million
Q2 2024

Jul 19, 2024
BUY
$92.57 - $107.37 $225,778 - $261,875
2,439 Added 20.98%
14,066 $1.5 Million
Q1 2024

Apr 26, 2024
SELL
$95.27 - $108.47 $4,572 - $5,206
-48 Reduced 0.41%
11,627 $1.12 Million
Q4 2023

Feb 06, 2024
SELL
$92.27 - $101.54 $26,481 - $29,141
-287 Reduced 2.4%
11,675 $1.18 Million
Q3 2023

Oct 27, 2023
SELL
$94.73 - $105.13 $947 - $1,051
-10 Reduced 0.08%
11,962 $1.22 Million
Q2 2023

Aug 03, 2023
BUY
$92.52 - $104.91 $9,529 - $10,805
103 Added 0.87%
11,972 $1.21 Million
Q1 2023

May 15, 2023
SELL
$80.03 - $92.81 $22,648 - $26,265
-283 Reduced 2.33%
11,869 $1.09 Million
Q4 2022

Feb 10, 2023
SELL
$75.55 - $92.52 $137,954 - $168,941
-1,826 Reduced 13.06%
12,152 $1.1 Million
Q3 2022

Nov 09, 2022
SELL
$74.61 - $87.26 $66,552 - $77,835
-892 Reduced 6.0%
13,978 $1.06 Million
Q2 2022

Aug 02, 2022
SELL
$80.52 - $93.75 $18,519 - $21,562
-230 Reduced 1.52%
14,870 $1.26 Million
Q1 2022

May 10, 2022
SELL
$80.11 - $90.62 $117,040 - $132,395
-1,461 Reduced 8.82%
15,100 $1.33 Million
Q4 2021

Feb 09, 2022
SELL
$79.7 - $88.13 $202,677 - $224,114
-2,543 Reduced 13.31%
16,561 $1.45 Million
Q3 2021

Nov 15, 2021
BUY
$81.78 - $95.14 $61,662 - $71,735
754 Added 4.11%
19,104 $1.56 Million
Q3 2021

Nov 09, 2021
BUY
$81.78 - $95.14 $912,501 - $1.06 Million
11,158 Added 155.14%
18,350 $1.5 Million
Q2 2021

Aug 09, 2021
SELL
$85.24 - $94.15 $590,116 - $651,800
-6,923 Reduced 49.05%
7,192 $656,000
Q1 2021

May 11, 2021
SELL
$83.5 - $98.47 $5.3 Million - $6.25 Million
-63,482 Reduced 81.81%
14,115 $1.21 Million
Q4 2020

Feb 11, 2021
BUY
$78.07 - $94.43 $257,474 - $311,430
3,298 Added 4.44%
77,597 $7.33 Million
Q3 2020

Nov 12, 2020
BUY
$82.14 - $91.0 $243,380 - $269,633
2,963 Added 4.15%
74,299 $6.46 Million
Q2 2020

Jul 31, 2020
BUY
$80.93 - $91.1 $421,402 - $474,357
5,207 Added 7.87%
71,336 $6.23 Million
Q1 2020

May 05, 2020
BUY
$70.67 - $99.01 $414,762 - $581,089
5,869 Added 9.74%
66,129 $5.45 Million
Q4 2019

Jan 07, 2020
BUY
$84.35 - $95.37 $281,897 - $318,726
3,342 Added 5.87%
60,260 $5.71 Million
Q3 2019

Oct 23, 2019
BUY
$85.54 - $94.26 $65,267 - $71,920
763 Added 1.36%
56,918 $4.95 Million
Q2 2019

Aug 05, 2019
BUY
$75.4 - $92.8 $355,284 - $437,273
4,712 Added 9.16%
56,155 $0
Q1 2019

Apr 26, 2019
BUY
$75.32 - $86.15 $407,029 - $465,554
5,404 Added 11.74%
51,443 $0
Q4 2018

Feb 11, 2019
BUY
$73.66 - $82.02 $338,688 - $377,127
4,598 Added 11.1%
46,039 $3.54 Million
Q3 2018

Nov 05, 2018
BUY
$66.94 - $77.43 $1.07 Million - $1.24 Million
16,053 Added 63.23%
41,441 $0
Q3 2018

Nov 05, 2018
SELL
$66.94 - $77.43 $947,134 - $1.1 Million
-14,149 Reduced 35.79%
25,388 $0
Q2 2018

Aug 07, 2018
BUY
$64.91 - $73.36 $151,759 - $171,515
2,338 Added 6.29%
39,537 $0
Q1 2018

May 02, 2018
BUY
$70.39 - $84.15 $182,028 - $217,611
2,586 Added 7.47%
37,199 $0
Q4 2017

Jan 25, 2018
BUY
$72.33 - $77.64 $115,077 - $123,525
1,591 Added 4.82%
34,613 $0
Q3 2017

Nov 09, 2017
SELL
$74.14 - $77.27 $14,086 - $14,681
-190 Reduced 0.57%
33,022 $0
Q2 2017

Aug 14, 2017
BUY
N/A
33,212
33,212 $0

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email